
129. Penicillin allergy 3: CEPH FAST
About this episode
AKA Penicillin Allergy 3: Delabel Hard With A Vengeance
A departure from our semi-annual penicillin allergy episode: one on cephalosporin allergy!
Jame and Callum are joined by Fionnuala Cox to discuss Cephalosporin allergy in general, and the CEPH-FAST risk assessment tool in particular.
Ever wanted to know how to deal with cephalosporin allergy? Listen on!
Paper here:
Cox F, Vogrin S, Sullivan RP, Stone C, Koo G, Phillips E, et al. Development and validation of a cephalosporin allergy clinical decision rule. Journal of Infection. 2025 June 1;90(6). Available from: https://www.journalofinfection.com/article/S0163-4453(25)00089-1/fulltext
https://doi.org/10.1016/j.jinf.2025.106495
(It's open access, don't worry)
Sign up for the BIA Autumn trainees meeting 2026 here: BIA Autumn Trainees Meeting 2026 | British Infection Association (BIA)
Support us on:
Patreon: https://www.patreon.com/cw/IDIOTS_pod
BuyMeACoffee: https://www.buymeacoffee.com/idiotspod
Prep notes for completed episodes can be found here (Not all episodes have prep notes).
If you are enjoying the podcast please leave a review on your preferred podcast app!
Get every episode summarized
Each time ID:IOTS - Infectious Disease Insight Of Two Specialists publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from ID:IOTS - Infectious Disease Insight Of Two Specialists

146. PD target attainment
ID:IOTS - Infectious Disease Insight Of Two Specialists

145. POETry in Motion
ID:IOTS - Infectious Disease Insight Of Two Specialists

144. Choosing an antimicrobial part 2: Microbe, host & drug factors
ID:IOTS - Infectious Disease Insight Of Two Specialists

143. Paediatric Antimicrobial Stewardship in the UK
ID:IOTS - Infectious Disease Insight Of Two Specialists